2-[(4-Benzoyloxybenzoyl)amino]acetic acid

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 缩酚酸和缩酚酸环醚类
• 英文名称: 2-[(4-Benzoyloxybenzoyl)amino]acetic acid
• 英文别名: 2-[(4-benzoyloxybenzoyl)amino]acetic acid
• 化学式: C₁₆H₁₃NO₅
• 分子量: 299.28
• InChiKey: KTQCDDUZPGCBFW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  92.7
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION
  申请人：Ospedale San Raffaele S.r.l.

  公开号：EP2914962A1

  公开（公告）日：2015-09-09
• A STREAMLINED METHOD FOR ANALYTICAL VALIDATION OF BIOCHEMICALS DETECTED USING AN UNTARGETED MASS-SPECTROMETRY PLATFORM
  申请人：Metabolon, Inc.

  公开号：EP3694646A1

  公开（公告）日：2020-08-19
• [EN] BIOMARKERS OF MULTIPLE MYELOMA DEVELOPMENT AND PROGRESSION<br/>[FR] BIOMARQUEURS DU DÉVELOPPEMENT ET DE LA PROGRESSION D'UN MYÉLOME MULTIPLE
  申请人：OSPEDALE SAN RAFFAELE SRL

  公开号：WO2014068144A1

  公开（公告）日：2014-05-08

  The present invention relates to a method for the prognosis of Symptomatic Multiple Myeloma (MM) and/or to monitor the response and/or the efficacy of a MM therapy comprising detecting and/or quantifying at least one marker, to relative kit and uses thereof and to relative microarray and use thereof. Markers include C3f peptide or a fragment thereof and/or other metabolites.
• [EN] A STREAMLINED METHOD FOR ANALYTICAL VALIDATION OF BIOCHEMICALS DETECTED USING AN UNTARGETED MASS-SPECTROMETRY PLATFORM<br/>[FR] PROCÉDÉ SIMPLIFIÉ DE VALIDATION ANALYTIQUE DE PRODUITS BIOCHIMIQUES DÉTECTÉS À L'AIDE D'UNE PLATE-FORME DE SPECTROMÉTRIE DE MASSE NON CIBLÉE
  申请人：METABOLON INC

  公开号：WO2019074757A1

  公开（公告）日：2019-04-18

  A method of assessing the analytical performance of a biochemical measured using a multi-analyte assay is described. The method includes analytically validating a measurement of the level of a first biochemical in a sample, wherein the first biochemical has been previously analytically validated for three or more analytical validation conditions; measuring the level of a second biochemical in a sample, wherein the second biochemical is structurally or biochemically related to the first biochemical; and comparing validation parameters of the first biochemical with validation parameters of the second biochemical to determine whether the performance of the second biochemical is acceptable based on the comparison results.